Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A syndrome is characterized by major seizures, dysmorphic features (round face, bulbous nose, wide mouth, prominent philtrum), pes planus, psychomotor retardation and obesity. It has been described in five children (three boys and two girls, one of whom died in infancy) from two unrelated Mexican families. This condition is likely to be transmitted as an autosomal recessive trait.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Hernández-Aguirre Negrete syndrome.
29 publications have been identified in PubMed for Hernández-Aguirre Negrete syndrome. Research spans Case Report / Case Series (54%), Basic Science / Preclinical (19%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 14 | 54% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Hernández-Aguirre Negrete syndrome
Laboratory research
5 |
19% |
Research summaries | 4 | 15% |
Disease patterns and progression | 2 | 8% |
Clinical study results | 1 | 4% |
Currow D (2026). [PMID: 41472644](https://pubmed.ncbi.nlm.nih.gov/41472644/). *J Palliat Med*. [Clinical Trial Publication]
Meneses V (2025). [PMID: 41396259](https://pubmed.ncbi.nlm.nih.gov/41396259/). *J Dev Behav Pediatr*. [Case Report / Case Series]
Qi R (2025). [PMID: 41393301](https://pubmed.ncbi.nlm.nih.gov/41393301/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
Arsenault LE (2025). [PMID: 40600106](https://pubmed.ncbi.nlm.nih.gov/40600106/). *Cureus*. [Case Report / Case Series]
Lindsay ME (2025). [PMID: 39243984](https://pubmed.ncbi.nlm.nih.gov/39243984/). *J Allergy Clin Immunol*. [Basic Science / Preclinical]
Yeter B (2025). [PMID: 40742416](https://pubmed.ncbi.nlm.nih.gov/40742416/). *Eur J Pediatr*. [Case Report / Case Series]
Chen J (2025). [PMID: 40031105](https://pubmed.ncbi.nlm.nih.gov/40031105/). *Comput Biol Med*. [Epidemiology / Natural History]
Li Y (2025). [PMID: 39912399](https://pubmed.ncbi.nlm.nih.gov/39912399/). *J Biosci*. [Review / Meta-Analysis]
Strych L (2025). [PMID: 39925176](https://pubmed.ncbi.nlm.nih.gov/39925176/). *Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub*. [Case Report / Case Series]
Nanda A (2025). [PMID: 39910735](https://pubmed.ncbi.nlm.nih.gov/39910735/). *Pediatr Dermatol*. [Case Report / Case Series]